Advertisement

Browse Subject Areas

?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Safety and antitumor activity of the anti–PD-1 antibody pembrolizumab in patients with advanced colorectal carcinoma

Fig 4

Kaplan-Meier estimates of survival.

(A) Progression-free survival. (B) Overall survival.

Fig 4

doi: https://doi.org/10.1371/journal.pone.0189848.g004